TY - JOUR
T1 - Rational use of oral antibiotics for pediatric infections
AU - Sunakawa, K.
AU - Akita, H.
AU - Iwata, S.
AU - Sato, Y.
AU - Fujii, R.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1995/3
Y1 - 1995/3
N2 - We carried out a survey in Japan to investigate compliance among children given oral antibiotics in an outpatient setting. The results of our survey revealed that, in Japan, approximately one-quarter of patients did not take their full course of antibiotics. Reasons for unsupervised self-discontinuation included: (1) the parent or guardian judged the infection to be cured; (2) the child refused to take the drug; and (3) the appearance of side effects. Causative organisms often involved in respiratory infections experienced in outpatient medicine include pneumococci, streptococci, staphylococci, Haemophilus influenzae, Moraxella (Branhamella) catarrhalis and Mycoplasma pneumoniae. The β-lactams are effective against all of these bacterial species, with the exception of M. pneumoniae. We conducted a survey of β-lactam antibiotics currently on the Japanese market and compared them to other oral antibiotics used to treat respiratory infections. Ease of administration, based on the incidence of adverse effects, particularly diarrhea, the dosage form, taste, dosage per administration and the number of doses required per day, are reported.
AB - We carried out a survey in Japan to investigate compliance among children given oral antibiotics in an outpatient setting. The results of our survey revealed that, in Japan, approximately one-quarter of patients did not take their full course of antibiotics. Reasons for unsupervised self-discontinuation included: (1) the parent or guardian judged the infection to be cured; (2) the child refused to take the drug; and (3) the appearance of side effects. Causative organisms often involved in respiratory infections experienced in outpatient medicine include pneumococci, streptococci, staphylococci, Haemophilus influenzae, Moraxella (Branhamella) catarrhalis and Mycoplasma pneumoniae. The β-lactams are effective against all of these bacterial species, with the exception of M. pneumoniae. We conducted a survey of β-lactam antibiotics currently on the Japanese market and compared them to other oral antibiotics used to treat respiratory infections. Ease of administration, based on the incidence of adverse effects, particularly diarrhea, the dosage form, taste, dosage per administration and the number of doses required per day, are reported.
UR - http://www.scopus.com/inward/record.url?scp=0028790006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028790006&partnerID=8YFLogxK
U2 - 10.1007/BF01742988
DO - 10.1007/BF01742988
M3 - Article
C2 - 8537136
AN - SCOPUS:0028790006
SN - 0300-8126
VL - 23
SP - S74-S78
JO - Infection
JF - Infection
IS - 2 Supplement
ER -